Chicago, IL, United States of America

Tamas Virag

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Memphis, TN (US) (2005)
  • Chicago, IL (US) (2007 - 2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tamas Virag - Pioneering Innovations in LPA Receptor Research

Introduction

Tamas Virag is a prominent inventor based in Chicago, IL, who has made significant contributions to the field of pharmaceutical sciences. With three patents to his name, he focuses on the development of innovative compounds and methods that target LPA receptors, demonstrating his dedication to advancing medical research and therapies.

Latest Patents

Virag's latest patents revolve around LPA receptor agonists and antagonists, and their various applications in medicine. The disclosed compounds, formulated according to specific chemical structures, are incorporated into pharmaceutical compositions designed to leverage their activity as either agonists or antagonists of LPA receptors. These inventions aim to modulate LPA receptor activity in several therapeutic contexts, including the treatment of cancer, enhancement of cell proliferation, management of wounds, and preservation of cellular function. The innovations also hold potential in treating dermatological conditions, making them highly relevant in contemporary medical practices.

Career Highlights

Throughout his career, Tamas Virag has been associated with the University of Tennessee Research Foundation, where he has honed his research skills and collaborated with leading experts in his field. His extensive work and dedication to innovative research have established him as a notable figure within the realm of pharmaceutical sciences.

Collaborations

Virag has collaborated with esteemed colleagues such as Duane Douglas Miller and Gabor G Tigyi, contributing to a rich environment of knowledge exchange and innovation. These partnerships have further propelled his research initiatives, allowing him to explore various aspects of LPA receptor pharmacology.

Conclusion

Tamas Virag's innovative work with LPA receptor agonists and antagonists exemplifies the potential of research to transform medical treatments. His contributions not only advance scientific knowledge but also offer hope for improved therapeutic strategies in diverse medical applications. Through his patents and collaborations, Virag continues to pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…